BAY 30554, also known as 2-(4-chlorophenyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole, is a potent and selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4), which plays a crucial role in the regulation of glucose homeostasis. This chemical compound has been extensively studied for its potential therapeutic applications in the treatment of type 2 diabetes, as it can enhance the action of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), leading to improved insulin secretion and reduced glucagon release. BAY 30554 has demonstrated promising results in preclinical studies, showing significant glucose-lowering effects and potential for further development as an anti-diabetic agent.
The CAS Registry Mumber 3305-16-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,0 and 5 respectively; the second part has 2 digits, 1 and 6 respectively. Calculate Digit Verification of CAS Registry Number 3305-16: (6*3)+(5*3)+(4*0)+(3*5)+(2*1)+(1*6)=56 56 % 10 = 6 So 3305-16-6 is a valid CAS Registry Number.